Melatonin
From Glioblastoma Treatments
Revision as of 08:29, 27 March 2024 by
Lazy
(
talk
|
contribs
)
(Blanked the page)
(
diff
)
← Older revision
|
Latest revision
(
diff
) |
Newer revision →
(
diff
)
Jump to navigation
Jump to search
Facts
... more about "
Melatonin
"
RDF feed
Has OS with
6 out of 14 patients were alive after one year
+
Has OS without
1 out of 16 patients was alive after one year.
+
Has PFS with
Not specified
+
Has PFS without
Not specified
+
Has Toxicity Explanation
Melatonin is considered to have a low toxicity level, with no known toxic side effects. It is generally regarded as safe for use in the dosages typically administered for both sleep disorders and experimental cancer treatment protocols.
+
Has Toxicity Level
1
+
Has Usefulness Rating
4
+
Has clinical trial phase
Phase-2 and Phase-3 trials
+
Has common side effects
No known toxic side effects
+
Has treatment name
Melatonin
+
Navigation menu
Page actions
Page
Discussion
Read
View source
History
Refresh
Page actions
Page
Discussion
More
Tools
Personal tools
Create account
Log in
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Search
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information
Cite this page
Browse properties
